Doctor profile · Federal record
Dr. Matthew Beal, MD
Dermatology Physician (CMS: Dermatology) · Student in an Organized Health Care Education/Training Program · Tucson, AZ
- NPI 1881913846
- Accepts Medicare
- MIPS 71.0 / 100 · 2023
- 17 yrs in practice
- Male
- Solo practice
- No sanctions
Practice & contact
- Primary practice
-
5150 E Glenn St
Tucson, AZ 857121337
(520) 795-7729
fax (520) 795-4177
Credentials & registration
- NPI registered
- May 2010 — 16 yrs on file
- Profile last updated
- September 17, 2020
- Year of graduation
- 2009 — 17 yrs since
- Specialty taxonomy
- 207N00000X — NUCC code
- State license (1)
- Arizona #47563
- Medicaid
- AZ #838508
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1881913846. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
13,380
Distinct HCPCS
10
Medicare allowed
$501,104
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
17003 |
Destruction of precancer skin growth, 2-14 growths | 4,911 | 610 | $6 | |
J7345 |
Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg | 3,200 | 15 | $2 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 1,468 | 970 | $88 | |
17000 |
Destruction of precancer skin growth, 1 growth | 1,113 | 743 | $43 | |
11102 |
Biopsy of related skin growth, first growth | 958 | 712 | $93 | |
17110 |
Destruction of skin growth, 1-14 growths | 263 | 223 | $105 | |
17262 |
Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | 233 | 195 | $162 | |
11103 |
Biopsy of related skin growth, each additional growth | 202 | 170 | $49 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 178 | 163 | $124 | |
99212 |
Established patient office or other outpatient visit, 10-19 minutes | 161 | 153 | $55 |
In context: peer comparison
Among 17 peers in Tucson Dermatology Physician, average services per provider: 310. This provider delivers 43× the peer median.Open Payments
Industry payments received
All-time total
$1,202
Transactions
54
Manufacturers
13
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Genzyme Corporation | 12 | $353.09 | |
| Abbvie INC. | 20 | $346.52 | |
| Sun Pharmaceutical Industries INC. | 4 | $83.92 | |
| Leo Pharma INC. | 2 | $63.04 | |
| Novartis Pharmaceuticals Corporation | 2 | $56.07 | |
| Regeneron Healthcare Solutions, INC. | 2 | $55.32 | |
| Lilly USA, LLC | 2 | $55.21 | |
| Ucb, INC. | 2 | $53.32 | |
| Amgen INC. | 2 | $43.88 | |
| Pfizer INC. | 3 | $39.92 | |
| Arcutis Biotherapeutics, INC. | 1 | $21.13 | |
| Janssen Biotech, INC. | 1 | $15.80 | |
| Galderma Laboratories, L.P. | 1 | $14.80 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
958
Patients
601
Total drug cost
$254,970
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Triamcinolone Acetonide | Generic | 221 | 156 | $2,560 |
| Ketoconazole | Generic | 136 | 85 | $2,761 |
| Clobetasol Propionate | Generic | 129 | 94 | $5,352 |
| Doxycycline Hyclate | Generic | 82 | 57 | $2,633 |
| Valacyclovir (Valacyclovir Hcl) | Brand | 68 | 40 | $1,991 |
| Hydrocortisone | Generic | 64 | 46 | $375 |
| Fluorouracil | Generic | 39 | 31 | $2,399 |
| Dupixent Pen (Dupilumab) | Brand | 35 | 0 | $132,672 |
| Mupirocin | Generic | 33 | 30 | $270 |
| Prednisone | Generic | 30 | 26 | $87 |
Frequently asked questions
What is Dr. Matthew Beal's medical specialty?
Dr. Matthew Beal practices Dermatology Physician in Tucson, AZ.
Where does Dr. Matthew Beal practice?
Dr. Matthew Beal practices at 5150 E Glenn St, Tucson, AZ 857121337. Office phone: 5207957729.
What is Dr. Matthew Beal's NPI?
Dr. Matthew Beal's National Provider Identifier (NPI) is 1881913846, issued by NPPES.
Does Dr. Matthew Beal accept Medicare assignment?
Yes. Dr. Matthew Beal accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Matthew Beal commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg (HCPCS J7345); Established patient office or other outpatient visit (HCPCS 99213). Source: CMS Medicare Physician & Other Practitioners file.